NCT05916521View on ClinicalTrials.gov

A Three Month Bleeding-Model Clinical Study

NACompletedINTERVENTIONAL
Enrollment

90

Participants

Timeline

Start Date

November 15, 2021

Primary Completion Date

February 11, 2022

Study Completion Date

February 11, 2022

Conditions
Gingivitis
Interventions
DRUG

0.454% stannous fluoride

Brush two times daily

DRUG

0.76% sodium monofluorophosphate

Brush two times daily

DRUG

0.454% stannous fluoride AM and 0.76% sodium monofluorophosphate PM

Brush two times daily

Trial Locations (1)

89146

Silverstone Research Group, Las Vegas

All Listed Sponsors
lead

Procter and Gamble

INDUSTRY

NCT05916521 - A Three Month Bleeding-Model Clinical Study | Biotech Hunter | Biotech Hunter